<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>HBUT-China: Judging Session</title>
        <link>https://video.igem.org/videos/watch/330e9420-7de1-4f32-9104-40bec79dee07</link>
        <description>MSS-type colorectal cancer (CRC) is a classic "cold tumor": most immunotherapies fail in this population, and systemic treatments such as chemotherapy carry severe side effects. To address this unmet need, we engineered oHSV2-Neo-IL-2 — an oncolytic herpesvirus type 2 armed with an AI-designed attenuated interleukin-2 variant. Knockout of ICP34.5 and ICP47 confers tumor-specific replication and restores MHC-I antigen presentation. Neo-IL-2 retains CD122/CD132 binding while losing CD25 affinity, activating effector T cells without expanding immunosuppressive Tregs. The project was guided by our HOPES human-practices framework, which integrates patient interviews with clinical-translation planning, and the SHIELD safety framework, spanning molecular design to cross-team biosafety resources. Combining computational screening with in vitro and in vivo validation, we aim to deliver a tolerable, effective therapy for MSS CRC patients who currently have limited treatment options.</description>
        <lastBuildDate>Sat, 21 Nov 2026 23:12:35 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>HBUT-China: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/330e9420-7de1-4f32-9104-40bec79dee07</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=330e9420-7de1-4f32-9104-40bec79dee07" rel="self" type="application/rss+xml"/>
    </channel>
</rss>